Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA

Charles L. Bennett, Oliver A. Sartor, James O. Armitage, Hagop Kantarjian

Research output: Contribution to journalComment/debatepeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)22-23
Number of pages2
JournalThe Lancet Oncology
Issue number1
StatePublished - Jan 1 2017

ASJC Scopus subject areas

  • Oncology

Cite this